Wipro Board Reconstitution Following Retirement of Two Independent Directors

Wipro has announced the retirement of two Independent Directors, Dr. Patrick J. Ennis and Mr. Patrick Dupuis, effective March 31, 2026, upon completion of their tenure. Consequently, the Board has re-constituted two key committees, the Nomination and Remuneration Committee and the Administrative and Shareholders/Investors Grievance Committee, effective April 1, 2026, with new member compositions announced.

Independent Director Retirements Confirmed

Wipro Limited has formally notified stock exchanges regarding the retirement of two members from its Board of Directors. The retiring directors are Dr. Patrick J. Ennis (DIN: 07463299) and Mr. Patrick Dupuis (DIN: 07480046), both serving as Independent Directors. Their retirement is effective at the close of business hours on March 31, 2026, following the completion of their stipulated tenure under the relevant provisions of the Companies Act, 2013.

Board Committee Re-constitution Effective April 1, 2026

As a direct consequence of the retirements, the Board has undertaken a re-constitution of its standing committees, effective from April 1, 2026. The changes affect the following key bodies:

Nomination and Remuneration Committee

This committee, which also functions as the Corporate Social Responsibility Committee, will now feature the following composition:

  • Ms. Tulsi Naidu, Chairperson
  • Mr. Deepak M Satwalekar, Member
  • Ms. Päivi Rekonen, Member

Administrative and Shareholders/Investors Grievance Committee

This committee, also known as the Stakeholders Relationship Committee, has been re-constituted as follows:

  • Mr. Deepak M Satwalekar, Chairman
  • Mr. Rishad A. Premji, Member
  • Ms. Päivi Rekonen, Member

Regulatory Compliance Details

The announcement confirms that the required details concerning the cessation of directorships, as stipulated by the listing regulations and related circulars, are appended in Annexure-A of the disclosure. The regulatory filings indicate that the changes pertain solely to the retirement of the directors upon completion of their tenure, with no other immediate appointments or changes in relationships disclosed.

Source: BSE

Previous Article

Zydus Lifesciences Organizational Realignment Sees Senior Management Transition for Mr. Mayank Satpal

Next Article

Apollo Hospitals Enterprise Limited Subsidiary Acquires 100% Stake in New Consumer Products Firm